Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$393M |
| 2 |
Baker Hughes
BKR
|
+$69.8M |
| 3 |
ExxonMobil
XOM
|
+$69.8M |
| 4 |
Apple
AAPL
|
+$63.5M |
| 5 |
Microsoft
MSFT
|
+$55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$250M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$229M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$175M |
| 4 |
BHI
Baker Hughes
BHI
|
+$134M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$53.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.85% |
| 2 | Financials | 14.71% |
| 3 | Healthcare | 13.11% |
| 4 | Industrials | 11.16% |
| 5 | Consumer Discretionary | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2051
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.62M | ﹤0.01% |
60,716
+23,663
| +64% | +$1.43M |
|
2052
Haverty Furniture Companies
HVT
$443M
| $3.62M | ﹤0.01% |
138,362
+29,877
| +28% | +$714K |
|
2053
Impinj
PI
$5.32B
| $3.62M | ﹤0.01% |
86,956
+56,856
| +189% | +$2.39M |
|
2054
Melco Resorts & Entertainment
MLCO
$2.16B
| $3.61M | ﹤0.01% |
149,578
+14,771
| +11% | +$321K |
|
|
FLIC
2055
DELISTED
First of Long Island Corp
FLIC
| $3.6M | ﹤0.01% |
118,273
+6,145
| +5% | +$171K |
|
|
XENT
2056
DELISTED
Intersect ENT, Inc
XENT
| $3.6M | ﹤0.01% |
115,439
+20,700
| +22% | +$613K |
|
2057
PTC Therapeutics
PTCT
$6.15B
| $3.58M | ﹤0.01% |
178,795
+24,366
| +16% | +$477K |
|
|
AD
2058
Array Digital Infrastructure
AD
$3.01B
| $3.56M | ﹤0.01% |
100,531
+13,600
| +16% | +$512K |
|
2059
First Bancorp
FBNC
$2.7B
| $3.56M | ﹤0.01% |
103,363
+4,910
| +5% | +$154K |
|
|
KERX
2060
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $3.52M | ﹤0.01% |
495,896
+54,790
| +12% | +$394K |
|
2061
German American Bancorp
GABC
$1.89B
| $3.52M | ﹤0.01% |
92,523
+2,259
| +3% | +$76.7K |
|
2062
Heritage Financial
HFWA
$1.21B
| $3.51M | ﹤0.01% |
119,078
+6,302
| +6% | +$169K |
|
|
LCI
2063
DELISTED
Lannett Company, Inc.
LCI
| $3.49M | ﹤0.01% |
47,336
+8,928
| +23% | +$655K |
|
|
COUP
2064
DELISTED
Coupa Software Incorporated
COUP
| $3.48M | ﹤0.01% |
111,772
-12,540
| -10% | -$382K |
|
2065
US Physical Therapy
USPH
$1.22B
| $3.47M | ﹤0.01% |
56,510
+2,873
| +5% | +$175K |
|
|
SCMP
2066
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $3.47M | ﹤0.01% |
294,181
+47,385
| +19% | +$532K |
|
|
BMTC
2067
DELISTED
Bryn Mawr Bank Corp
BMTC
| $3.47M | ﹤0.01% |
79,177
+4,335
| +6% | +$181K |
|
2068
Virtus Investment Partners
VRTS
$1.11B
| $3.46M | ﹤0.01% |
29,848
-2,776
| -9% | -$310K |
|
|
MYOK
2069
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.46M | ﹤0.01% |
80,718
+23,172
| +40% | +$739K |
|
|
SGY
2070
DELISTED
Stone Energy
SGY
| $3.44M | ﹤0.01% |
118,457
+23,793
| +25% | +$570K |
|
2071
SolarEdge
SEDG
$2.05B
| $3.44M | ﹤0.01% |
120,480
+18,914
| +19% | +$477K |
|
|
TGH
2072
DELISTED
Textainer Group Holdings limited
TGH
| $3.43M | ﹤0.01% |
200,162
-76,950
| -28% | -$1.23M |
|
|
FBC
2073
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $3.42M | ﹤0.01% |
96,451
+4,980
| +5% | +$160K |
|
2074
Gogo Inc
GOGO
$392M
| $3.42M | ﹤0.01% |
289,475
+27,186
| +10% | +$347K |
|
2075
OceanFirst Financial
OCFC
$1.84B
| $3.4M | ﹤0.01% |
123,572
+13,958
| +13% | +$364K |
|
Similar funds
Charles Schwab's Q3 2017 Portfolio in Review
As of Q3 2017, Charles Schwab held 3,155 positions worth $115B, up 7.6% from $106B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $3.77B of net new capital in Q3 2017, opening 56 new positions and adding to 2,228 existing holdings. Its largest new stake was Baker Hughes: 1,967,118 shares worth $72M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Stanley Black & Decker, an estimated $45.1M trimmed.
- Charles Schwab's largest Q3 2017 buy was Baker Hughes: 1,967,118 shares worth $72M.
- Charles Schwab added most to DuPont de Nemours in Q3 2017, an estimated $393M increase.
- Charles Schwab's biggest Q3 2017 reduction was Stanley Black & Decker, cutting an estimated $45.1M.
- Charles Schwab fully exited Reynolds American Inc in Q3 2017, selling an estimated $250M.
- Charles Schwab's ten largest holdings make up 14% of its $115B portfolio in Q3 2017.
- Charles Schwab opened 56 new positions and closed 79 in Q3 2017.
- Charles Schwab's portfolio value rose 7.6% quarter-over-quarter to $115B.
Based on Charles Schwab's 13F filing for Q3 2017, filed 13 Nov 2017.